About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
Aspirin: Not a "Wonder Drug" Anymore?
By
Houston Methodist DeBakey Heart and Vascular Center
FEATURING
Miguel Cainzos-Achirica
By
Houston Methodist DeBakey Heart and Vascular Center
FEATURING
Miguel Cainzos-Achirica
433 views
January 25, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
13:03
Novartis Cardiology
Expert Insights on Adding a Non-Statin Lipid-Lowering Therapy in a R…
Feat.
M. Koren
Featured Video
10:56
Novartis Cardiology
Expert Insights on Pivotal Phase 3 and Long-term Trial Data in Prima…
Feat.
D. G. Karalis,
M. Myerson
Related Content
AUTOPLAY
ON
26:11
13th Orange County Symposium for Cardiovascular Disease Prevention
Update on Calcium Screening and CTA: Role in Prevention
Feat.
M. Budoff
12:04
Stephen Kopecky
Role of PCSK9 Inhibitors in Diabetes
18:43
Canadian Collaborative Research Network
Lp(a): When to Measure it and What to Do About it
Feat.
M. O'Donoghue
59:01
The North American Thrombosis Forum (NATF)
Recent Cholesterol Guidelines and Integration into Clinical Practice
Feat.
J. Plutzky,
L. Braun,
J. Ross
20:15
Omnipod®
Type 2 Diabetes and Omnipod® 5--Unveiling SECURE T2D
Feat.
F. Pasquel
21:34
Canadian Collaborative Research Network
Should Colchicine Become Standard Therapy for CAD?
Feat.
P. Ridker
15:40
ACC 2022 Conference Coverage
ACC 2022: Triple Therapy - When to Use and How Long
Feat.
D. Kumbhani
24:02
Complex Coronary Cases
Updated Lipid Guidelines and Therapy
Feat.
I. Fergus
08:44
AHA 2022 Conference Coverage
AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…
Feat.
N. Marston
21:27
Scripps Health
Lipids Update: Current Guidelines for Lipid Management
Feat.
S. R. Mehta
14:50
AHA 2022 Conference Coverage
AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…
Feat.
K. Ray
45:45
Houston Methodist DeBakey Heart and Vascular Center
Directions of Cardiology in the Next Decade: 2022-2032
Feat.
E. Braunwald
16:08
Omnipod®
Unlock the Future of Type 2 Diabetes Care (featuring Dr. Viral Shah)
Feat.
V. Shah
31:02
Scripps Health
How Do I Reverse Coronary Plaque?
Feat.
C. J. Suhar
07:22
Canadian Collaborative Research Network
TACT2 – Does Chelation Reduce Events in Diabetic Post-MI Patients?
Feat.
N. Singh
19:48
ACC 2022 Conference Coverage
ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "…
Feat.
R. Giugliano
28:11
Top Ten Topics in Clinical Cardiology 2021
Time to Retire Aspirin?
Feat.
R. Mehran
39:44
The Texas Heart Institute
Lipid Lowering Therapies: Where Did We Start, Where We Are Now and W…
Feat.
S. Virani
21:48
Canadian Collaborative Research Network
I Ordered an Lp(a) Level – Now What?
Feat.
M. O'Donoghue
33:43
Jefferson Health
Update on Lipids: Current Options for Lowering LDL to Reduce CV Risk
Feat.
A. Cohen